Literature DB >> 14719424

Levobupivacaine versus racemic bupivacaine in spinal anaesthesia for urological surgery.

Y Y Lee1, K Muchhal, C K Chan.   

Abstract

Racemic bupivacaine is the most common local anaesthetic used intrathecally. This prospective, randomized, double-blind study compared the clinical efficacy and motor block of 0.5% levobupivacaine with 0.5% racemic bupivacaine in spinal anaesthesia for urological surgery. The surgery required an upper level of sensory block of at least the tenth thoracic dermatome. Fifty patients were recruited (levobupivacaine group n = 24; bupivacaine group n = 26). Spinal anaesthesia was achieved with 2.6 ml of study solution injected in the subarachnoid space at the lumbar 3/4 interspace. One patient from the levobupivacaine group was excluded due to technical failure. There were no significant differences between the two groups in the quality of sensory and motor block or in haemodynamic change. Anaesthesia was adequate and patient satisfaction good in all cases. We conclude that 0.5% levobupivacaine can be used as an alternative to 0.5% racemic bupivacaine in spinal anaesthesia for surgery when a sensory block to at least T10 is required.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719424     DOI: 10.1177/0310057X0303100604

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  13 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

2.  Comparison of two different doses of intrathecal levobupivacaine for transurethral endoscopic surgery.

Authors:  Secil Dizman; Gurkan Turker; Alp Gurbet; Elif Basagan Mogol; Suat Turkcan; Ziyaatin Karakuzu
Journal:  Eurasian J Med       Date:  2011-08

3.  Hyperbaric levobupivacaine in anal surgery : Spinal perianal and spinal saddle blocks.

Authors:  Z Kazak; P Ekmekci; K Kazbek
Journal:  Anaesthesist       Date:  2010-07-30       Impact factor: 1.041

4.  A comparison of spinal anesthesia characteristics following intrathecal bupivacaine or levobupivacaine in lumbar disc surgery.

Authors:  Ayça Sultan Şahin; Gürkan Türker; Ahmet Bekar; Hülya Bilgin; Gülsen Korfalı
Journal:  Eur Spine J       Date:  2013-11-09       Impact factor: 3.134

5.  Effects of bupivacaine versus levobupivacaine on pulmonary function in patients with chronic obstructive pulmonary disease undergoing urologic surgery: a randomized, double-blind, controlled trial.

Authors:  Sevtap Hekimoglu Sahin; Mehmet Inal; Aysin Alagol; Alkin Colak; Cavidan Arar; Tughan Basmergen; Isil Gunday; F Nesrin Turan
Journal:  Curr Ther Res Clin Exp       Date:  2011-08

6.  Low dose levobupivacaine 0.5% with fentanyl in spinal anaesthesia for transurethral resection of prostate surgery.

Authors:  Erkan Yavuz Akcaboy; Zeynep Nur Akcaboy; Nermin Gogus
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

7.  Influence of positioning on plain levobupivacaine spinal anesthesia in cesarean section.

Authors:  Fabio Gori; Francesco Corradetti; Vittorio Cerotto; Vito Aldo Peduto
Journal:  Anesthesiol Res Pract       Date:  2010-05-24

8.  Bispectral index-guided general anaesthesia in combination with interscalene block reduces desflurane consumption in arthroscopic shoulder surgery: a clinical comparison of bupivacaine versus levobupivacaine.

Authors:  Levent Ozturk; Elvin Kesimci; Tuna Albayrak; Orhan Kanbak
Journal:  BMC Anesthesiol       Date:  2015-07-21       Impact factor: 2.217

9.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Spinal anesthesia for knee arthroscopy using isobaric bupivacaine and levobupivacaine: anesthetic and neuroophthalmological assessment.

Authors:  Monica del-Rio-Vellosillo; Jose Javier Garcia-Medina; Antonio Abengochea-Cotaina; Maria Dolores Pinazo-Duran; Manuel Barbera-Alacreu
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.